BIO
Bio-Rad Laboratories, Inc. Healthcare - Medical Devices Investor Relations →
Bio-Rad Laboratories, Inc. (BIO) closed at $301.50 as of 2026-02-02, trading 15.5% below its 200-week moving average of $356.73. This places BIO in the extreme value zone. The stock moved further from the line this week, up from -18.0% last week. The 14-week RSI sits at 42, indicating neutral momentum.
Over the past 2349 weeks of data, BIO has crossed below its 200-week moving average 27 times. On average, these episodes lasted 23 weeks. Historically, investors who bought BIO at the start of these episodes saw an average one-year return of +6.1%.
With a market cap of $8.1 billion, BIO is a mid-cap stock. The company generates a free cash flow yield of 2.9%. Return on equity stands at -9.5%. The stock trades at 1.2x book value.
The company has been aggressively buying back shares, reducing its share count by 6.4% over the past three years.
Over the past 33.2 years, a hypothetical investment of $100 in BIO would have grown to $5096, compared to $2849 for the S&P 500. That represents an annualized return of 12.6% vs 10.6% for the index — confirming BIO as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: BIO vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After BIO Crosses Below the Line?
Across 19 historical episodes, buying BIO when it crossed below its 200-week moving average produced an average return of +11.5% after 12 months (median +14.0%), compared to +15.6% for the S&P 500 over the same periods. 59% of those episodes were profitable after one year. After 24 months, the average return was +64.9% vs +33.7% for the index.
Each line shows $100 invested at the moment BIO crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
BIO has crossed below its 200-week MA 27 times with an average 1-year return of +6.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 1981 | Jun 1981 | 1 | 0.9% | -45.7% | +12520.9% |
| Jul 1981 | Jul 1981 | 1 | 1.0% | -52.7% | +12520.9% |
| Aug 1981 | Feb 1983 | 81 | 57.3% | -59.7% | +12520.9% |
| Nov 1987 | Dec 1987 | 5 | 21.0% | +33.3% | +6600.0% |
| Jan 1988 | Feb 1988 | 1 | 0.7% | +22.0% | +6032.2% |
| Dec 1988 | Mar 1989 | 15 | 8.0% | -12.7% | +4995.8% |
| May 1989 | May 1990 | 53 | 24.6% | +4.8% | +4890.3% |
| Jul 1990 | Feb 1991 | 27 | 34.8% | +5.9% | +4660.5% |
| Sep 1991 | Sep 1991 | 1 | 0.7% | +2.7% | +4822.4% |
| Oct 1991 | Dec 1991 | 10 | 5.2% | -7.5% | +4822.4% |
| Feb 1992 | May 1992 | 11 | 9.5% | -10.7% | +4724.0% |
| Jun 1992 | Jun 1992 | 2 | 1.6% | -23.1% | +4822.4% |
| Sep 1992 | Apr 1994 | 84 | 44.3% | -23.0% | +4789.2% |
| May 1994 | May 1994 | 1 | 1.1% | +94.2% | +5181.8% |
| May 1994 | Jun 1994 | 1 | 1.0% | +83.2% | +5181.8% |
| Feb 1998 | Feb 1998 | 3 | 5.0% | -14.0% | +2399.5% |
| Aug 1998 | Apr 1999 | 35 | 28.3% | +8.0% | +2300.0% |
| Jul 1999 | Feb 2000 | 32 | 18.0% | -8.0% | +2175.5% |
| Apr 2000 | Oct 2000 | 28 | 18.3% | +33.3% | +2213.7% |
| Nov 2008 | Jul 2009 | 38 | 26.9% | +39.0% | +330.7% |
| Aug 2010 | Aug 2010 | 1 | 2.5% | +19.5% | +264.5% |
| Sep 2011 | Oct 2011 | 3 | 2.1% | +19.4% | +234.3% |
| Nov 2011 | Dec 2011 | 3 | 2.1% | +15.5% | +234.9% |
| Oct 2014 | Oct 2014 | 2 | 3.2% | +28.0% | +177.4% |
| Nov 2014 | Nov 2014 | 2 | 1.6% | +26.9% | +172.6% |
| Jun 2022 | Jun 2022 | 1 | 3.0% | -18.8% | -35.0% |
| Aug 2022 | Ongoing | 180+ | 49.6% | Ongoing | -37.0% |
| Average | 23 | — | +6.1% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02